Annual report [Section 13 and 15(d), not S-K Item 405]

Note 14 - Stock-based Compensation (Tables)

v3.25.1
Note 14 - Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Notes To Financial Statements [Abstract]  
Share-based Payment Arrangement, Option, Activity

Stock option transactions for the year ended December 31, 2024 and December 31, 2023, are summarized as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options

 

 

Weighted average
exercise price

 

 

Weighted
average
remaining
contractual
life (years)

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2022

 

 

36,666

 

 

$

1,566.00

 

 

 

 

 

 

 

Granted

 

 

7,232

 

 

 

296.10

 

 

 

 

 

 

 

Forfeited

 

 

(4,433

)

 

 

1,526.10

 

 

 

 

 

 

 

Outstanding, December 31, 2023

 

 

39,465

 

 

$

1,343.40

 

 

 

 

 

 

 

Granted

 

 

13,606

 

 

 

59.97

 

 

 

 

 

 

 

Forfeited

 

 

(13,582

)

 

 

516.60

 

 

 

 

 

 

 

Outstanding, December 31, 2024

 

 

39,489

 

 

$

1,170.30

 

 

 

6.5

 

 

$

 

Exercisable, December 31, 2024

 

 

25,208

 

 

$

1,692.90

 

 

 

5.3

 

 

$

 

Vested and expected to vest, December 31, 2024

 

 

36,513

 

 

$

1,246.20

 

 

 

6.3

 

 

$

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table presents the weighted average assumptions that were used in the Black‑Scholes option pricing model to determine the fair value of stock options granted during the period, and the resultant weighted average fair values:

 

 

Year ended December 31, 2024

 

 

Year ended December 31, 2023

 

Risk-free interest rate

 

 

4.07

%

 

 

3.42

%

Expected dividend yield

 

 

 

 

 

 

Expected volatility

 

 

83.1

%

 

 

80.3

%

Expected life of options (years)

 

 

5

 

 

 

5

 

Grant date fair value

 

$

40.80

 

 

$

195.90

 

Schedule of Share-based Payment Award, Options, Grants in Period

The following table presents the vesting terms of options granted in the period:

 

 

 

Year ended December 31, 2024

 

 

Year ended December 31, 2023

 

 

 

 

 

 

 

 

 

Options

 

 

Options

 

3-year vesting (50%-25%-25%)

 

 

667

 

 

 

1,611

 

4-year vesting (50%-16 2/3%-16 2/3%-16 2/3%)

 

 

12,939

 

 

 

5,621

 

Total stock options granted in the year

 

 

13,606

 

 

 

7,232

 

The Company has a stock incentive plan (SIP) pursuant to which the Board may grant stock-based awards comprised of restricted stock units or dividend equivalents to employees, officers, consultants, independent contractors, advisors and non-employee directors of the Company.
Share-based Payment Arrangement, Vesting and Redemption of the RSUs Granted

 

Year ended,
December 31, 2024

 

 

Year ended,
December 31, 2023

 

 

Number

 

 

Weighted average grant date fair value

 

 

Number

 

 

Weighted average grant date fair value

 

Outstanding, beginning of period

 

 

 

 

$

 

 

 

 

 

 

-

 

Granted

 

 

 

 

 

 

 

 

1,266

 

 

 

297.00

 

Vested

 

 

 

 

 

 

 

 

(1,266

)

 

 

(297.00

)

Outstanding, end of period

 

 

 

 

$

 

 

 

 

 

 

-

 

Share-based Payment Arrangement, Expensed and Capitalized, Amount

The Company recorded share-based payment expense related to stock options and RSUs as follows:

 

 

Year ended December 31, 2024

 

 

Year ended December 31, 2023

 

Research and development

 

$

346

 

 

$

1,373

 

General and administrative

 

 

714

 

 

 

2,280

 

Total

 

$

1,060

 

 

$

3,653